Circadian aspects of prostaglandin F2alpha-induced termination of pregnancy.
D000028:Abortion, Induced; D000032:Abortion, Therapeutic; D000328:Adult; D000653:Amniotic Fluid; D002940:Circadian Rhythm; D011431:Dextropropoxyphene / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004319:Doxylamine / Q000627:therapeutic use; D005260:Female; D006760:Hospitalization; D006801:Humans; D007267:Injections; D007902:Length of Stay; D008614:Meperidine / Q000627:therapeutic use; D010298:Parity; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011453:Prostaglandins / Q000008:administration & dosage / Q000627:therapeutic use*; D011736:Pyridoxine / Q000627:therapeutic use; D013997:Time Factors
D011453:Prostaglandins; D004319:Doxylamine; D008614:Meperidine; D011736:Pyridoxine; D011431:Dextropropoxyphene